Rain Therapeutics Competitors and Similar CompaniesClear all

Rain Therapeutics's competitors and similar companies include Five Prime Therapeutics, ImmunoGen and Aptevo Therapeutics.

	Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.	Five Prime Therapeutics Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.	ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.	Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Founding Date	Founding Date 2017	Founding Date 2001	Founding Date 1981	Founding Date 2016
Type	Type Public	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology
Locations	Locations Newark, US HQ	Locations South San Francisco, US HQ	Locations Waltham, US HQ	Locations Seattle, US HQ
Employees	Employees 6343% increase	Employees 5141% decrease	Employees 277161% increase	Employees 1182% decrease
Valuation ($)	Valuation ($) 44 m	Valuation ($) N/A	Valuation ($) 8.7 b	Valuation ($) 4.1 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $13.2m (FY, 2020)	Revenue (est.) $108.8m (FY, 2022)	Revenue (est.) N/A
Net income	Net income ($75.7m) (FY, 2022)	Net income ($84.3m) (FY, 2020)	Net income ($222.9m) (FY, 2022)	Net income ($26m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 82.4m	Total funding raised $ 237.2m	Total funding raised $ 56m	Total funding raised N/A